Using a viral vector for mutant (P301L) tau, we studied the effects of gene transfer to the rat substantia nigra in terms of structural and functional properties of dopaminergic neurons. The mutant tau vector caused progressive loss of pars compacta dopaminergic neurons over time, reduced striatal dopamine content, and amphetamine-stimulated rotational behavior consistent with a specific lesion effect. In addition, structural studies demonstrated neurofibrillary tangles and neuritic pathology. Wild-type tau had similar effects on neuronal loss and rotational behavior. In contrast, mutant a-synuclein vectors did not induce rotational behavior, although a-synuclein filaments formed in nigrostriatal axons. Dopamine neuron function is affected by tau gene transfer and appears to be more susceptible to tau-rather than asynuclein-related damage in this model. Both tau and a-synuclein are important for substantia nigra neurodegeneration models in rats, further indicating their potential as therapeutic targets for human diseases involving loss of dopamine neurons. D
Deposits of the microtubule-associated protein tau in the form of neurofibrillary tangles (NFTs) are characteristic of many neurodegenerative diseases including Alzheimer's disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and frontotemporal dementia with parkinsonism linked to chromosome 17 , and in all of these diseases, NFTs are expressed in the substantia nigra (SN; Mirra et al., 1999; Poorkaj et al., 2002; Schneider et al., 2002; Wakabayashi et al., 1994) . There is dramatic loss of pigmented SN neurons in PSP (Poorkaj et al., 2002) and FTDP-17 (Mirra et al., 1999) which may be causally related to toxic aggregation of tau. This study investigates the causal relationship of tau expression and SN dopamine neuron degeneration in an animal model.
Mutation in the tau gene causes FTDP-17 (Hutton et al., 1998), and particular variants are associated with increased risk for other parkinsonian disorders, including PSP (Baker et al., 1999) and CBD (Di Maria et al., 2000) . Variants may also be a risk factor for Parkinson's disease (PD; Healy et al., 2004; Martin et al., 2001 ). The P301L FTDP-17-related form of tau is particularly pathogenic as it exhibits accelerated filament formation in vitro (Nacharaju et al., 1999) and transgenic mice expressing P301L tau develop neurofibrillary tangles (NFTs; Lewis et al., 2000) . While idiopathic PD is not associated with NFTs, tau has been demonstrated in a subpopulation of Lewy bodies (Ishizawa et al., 2003) . Using a viral vector for P301L tau, we previously developed a rat model for NFT formation in the basal forebrain (Klein et al., 2004 ). Here we targeted wild type or P301L tau expression to the rat SN in order to study the causal relationship between neurofibrillary pathology and loss of dopamine neurons, as a number of tauopathies involve NFTs in and severe loss of pigmented neurons in the SN (Mirra et al., 1999; Poorkaj et al., 2002) .
Viral vector gene transfer offers unique advantages for modeling, particularly for targeting brain regions and ages most associated with specific diseases. While a-synuclein (ASN) vector gene transfer models share features with PD such as loss of SN dopaminergic neurons in our previous study (Klein et al., 2002a) and two others (Kirik et al., 2002; Lo Bianco et al., 2002) , motor dysfunction was not readily detected. To determine if the lack of behavioral effect was due to insufficient gene expression, we incorporated an enhancer element (Loeb et al., 1999) to boost ASN expression in this study. Because motor deficits are critical for a model of SN degeneration in order to test drugs and diets that could ameliorate symptoms, a goal of the present study was to generate a behaviorally significant gene transfer model. We used unilateral gene transfer to normal rats to study lateralized motor deficits and evaluate the functional significance of neuronal pathology. 
